CA2340616A1 - Proteines secretees et polynucleotides codant pour ces proteines - Google Patents
Proteines secretees et polynucleotides codant pour ces proteines Download PDFInfo
- Publication number
- CA2340616A1 CA2340616A1 CA002340616A CA2340616A CA2340616A1 CA 2340616 A1 CA2340616 A1 CA 2340616A1 CA 002340616 A CA002340616 A CA 002340616A CA 2340616 A CA2340616 A CA 2340616A CA 2340616 A1 CA2340616 A1 CA 2340616A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- nucleotide sequence
- nucleotide
- amino acid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Abstract
La présente invention concerne de nouveaux polynucléotides ainsi que les protéines codées par ces polynucléotides.
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9765998P | 1998-08-24 | 1998-08-24 | |
US9763898P | 1998-08-24 | 1998-08-24 | |
US9961898P | 1998-09-09 | 1998-09-09 | |
US10209298P | 1998-09-28 | 1998-09-28 | |
US10997898P | 1998-11-25 | 1998-11-25 | |
US11364598P | 1998-12-23 | 1998-12-23 | |
US11364698P | 1998-12-23 | 1998-12-23 | |
US37924699A | 1999-08-23 | 1999-08-23 | |
US60/097,638 | 1999-08-23 | ||
US60/113,646 | 1999-08-23 | ||
US60/097,659 | 1999-08-23 | ||
US09/379,246 | 1999-08-23 | ||
US60/109,978 | 1999-08-23 | ||
US60/099,618 | 1999-08-23 | ||
US60/113,645 | 1999-08-23 | ||
US60/102,092 | 1999-08-23 | ||
PCT/US1999/019351 WO2000011015A1 (fr) | 1998-08-24 | 1999-08-24 | Proteines secretees et polynucleotides codant pour ces proteines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2340616A1 true CA2340616A1 (fr) | 2000-03-02 |
Family
ID=27574713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002340616A Abandoned CA2340616A1 (fr) | 1998-08-24 | 1999-08-24 | Proteines secretees et polynucleotides codant pour ces proteines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1107978A1 (fr) |
JP (1) | JP2002537757A (fr) |
AU (1) | AU5784799A (fr) |
CA (1) | CA2340616A1 (fr) |
WO (1) | WO2000011015A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20020192659A1 (en) * | 1997-09-17 | 2002-12-19 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030054400A1 (en) * | 1997-09-17 | 2003-03-20 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7417126B2 (en) | 1997-10-17 | 2008-08-26 | Genentech, Inc. | PRO246 antibodies |
CZ304224B6 (cs) * | 1998-11-06 | 2014-01-15 | Schwab | Monoklonální protilátka |
JP2003534767A (ja) * | 1998-11-20 | 2003-11-25 | アリーナ・フアーマシユーチカルズ・インコーポレーテツド | ヒトオーファンgタンパク質共役型受容体 |
USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
US20030017528A1 (en) | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
US7816492B2 (en) | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
EP1159413A4 (fr) * | 1999-02-26 | 2005-12-14 | Millennium Pharm Inc | Proteines secretees et utilisations |
ATE348108T1 (de) * | 1999-03-08 | 2007-01-15 | Genentech Inc | Methode zum nachweis von tumoren |
EP1189944A4 (fr) * | 1999-06-21 | 2002-09-11 | Smithkline Beecham Corp | Axor16, r cepteur coupl une prot ine g |
EP1207201A4 (fr) * | 1999-08-27 | 2003-03-12 | Takeda Chemical Industries Ltd | Proteine recepteur couplee a une proteine g et adn correspondant |
AU7452300A (en) * | 1999-10-01 | 2001-05-10 | Kyowa Hakko Kogyo Co. Ltd. | Shear stress-response dna |
WO2001025444A2 (fr) * | 1999-10-07 | 2001-04-12 | Zymogenetics, Inc. | Nouvelle phosphodiesterase humaine: zcytor13 |
AU2055401A (en) * | 1999-12-01 | 2001-06-12 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2001087930A2 (fr) * | 2000-05-18 | 2001-11-22 | Bayer Aktiengesellschaft | Regulation du recepteur couple a la proteine g analogue au recepteur de la galanine humaine |
AU2001263105A1 (en) | 2000-05-18 | 2001-11-26 | Lexicon Genetics Incorporated | Human semaphorin homologs and polynucleotides encoding the same |
WO2002004518A2 (fr) * | 2000-07-06 | 2002-01-17 | Bayer Corporation | Recepteur humain couple aux proteines g de type neuropeptide y |
WO2002074237A2 (fr) * | 2001-03-19 | 2002-09-26 | Corixa Corporation | Compositions et procedes de therapie et de diagnostic du cancer du rein |
EP1293569A3 (fr) * | 2001-09-14 | 2004-03-31 | Research Association for Biotechnology | Clones d'ADNc complets |
JP2003088388A (ja) | 2001-09-14 | 2003-03-25 | Herikkusu Kenkyusho:Kk | 新規な全長cDNA |
GB2397577A (en) * | 2001-11-01 | 2004-07-28 | Amersham Plc | Human angiomotin-like protein 1 |
CN1324047C (zh) | 2002-04-12 | 2007-07-04 | 先灵公司 | G蛋白偶联受体的配体与方法 |
AU2003261874A1 (en) * | 2002-09-02 | 2004-03-29 | Takeda Pharmaceutical Company Limited | Adrenocortical hormone secretion controller |
FR2848569A1 (fr) * | 2002-12-17 | 2004-06-18 | Exonhit Therapeutics Sa | Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations |
WO2004106935A2 (fr) * | 2003-05-27 | 2004-12-09 | Bayer Healthcare Ag | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur 103 couples aux proteines g (gpr103) |
EP1733743A4 (fr) * | 2004-04-09 | 2007-06-27 | Takeda Pharmaceutical | Agents de prevention/remedes contre le cancer |
JPWO2005100566A1 (ja) | 2004-04-14 | 2008-03-06 | 萬有製薬株式会社 | 新規サルgpr103及びサルqrfp並びにgpr103を用いた化合物の評価方法 |
CN101772572A (zh) * | 2007-03-23 | 2010-07-07 | 新加坡科技研究局 | 提高神经前体细胞的迁移的方法 |
TR201910330T4 (tr) * | 2013-07-30 | 2019-07-22 | Sbi Biotech Co Ltd | Anti-fosfolin d4 antikoru içeren ilaç. |
-
1999
- 1999-08-24 WO PCT/US1999/019351 patent/WO2000011015A1/fr not_active Application Discontinuation
- 1999-08-24 JP JP2000566287A patent/JP2002537757A/ja active Pending
- 1999-08-24 CA CA002340616A patent/CA2340616A1/fr not_active Abandoned
- 1999-08-24 AU AU57847/99A patent/AU5784799A/en not_active Abandoned
- 1999-08-24 EP EP99945180A patent/EP1107978A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000011015A1 (fr) | 2000-03-02 |
EP1107978A1 (fr) | 2001-06-20 |
JP2002537757A (ja) | 2002-11-12 |
AU5784799A (en) | 2000-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2340616A1 (fr) | Proteines secretees et polynucleotides codant pour ces proteines | |
US20020193567A1 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998033916A2 (fr) | Proteines secretees et polynucleotides codant celles-ci | |
EP0998490A2 (fr) | Proteines secretees et polynucleotides les codant | |
WO1998055614A2 (fr) | Proteines secretees et polynucleotides codant ces proteines | |
EP0973890A2 (fr) | Proteines secretees et polynucleotides les codant | |
CA2306457A1 (fr) | Proteines secretees et polynucleotides les codant | |
WO1998027205A2 (fr) | Proteines secretees et polynucleotides codant pour lesdites proteines | |
CA2310214A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2324492A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2327551A1 (fr) | Proteines secretees et polynucleotides les codant | |
WO1998032853A2 (fr) | Proteines secretees et polynucleotides les codant | |
WO1998044113A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2322732A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2311683A1 (fr) | Proteines secretees et polynucleotides les codant | |
WO1998041539A2 (fr) | Proteines secretees et polynucleotides les codant | |
CA2309782A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2305689A1 (fr) | Proteines secretees et polynucleotides les codant | |
CA2325057A1 (fr) | Proteines secretees et polynucleotides codant pour celles-ci | |
EP0948620A2 (fr) | Proteines secretees et polynucleotides les codant | |
CA2318303A1 (fr) | Proteines secretees et polynucleotides les codant | |
EP0996721A2 (fr) | Proteines secretees et polynucleotides les codant | |
CA2324504A1 (fr) | Proteines secretees et polynucleotides les codant | |
EP1003855A2 (fr) | Proteines secretees et polynucleotides codant ces proteines | |
CA2309624A1 (fr) | Proteines secretees et polynucleotides codant ces proteines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |